Bone marrow with gelatinous transformation associated with residual disease in imatinib mesylate-treated chronic myelogenous leukaemia (CML)

Bone marrow with gelatinous transformation associated with residual disease in imatinib mesylate-treated chronic myelogenous leukaemia (CML)

Saved in:
Bibliographic Details
Published in:Pathology Vol. 44; no. 1; p. 59
Main Authors: Thakral, Beenu, Higa, Bryce, Venkataraman, Girish, Velankar, Milind M.
Format: Journal Article
Language:English
Published: England Elsevier B.V 01-01-2012
Subjects:
Aged
Antineoplastic Agents - therapeutic use
Benzamides
Biopsy, Needle
Bone Marrow - pathology
Humans
Imatinib Mesylate
Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy
Leukemia, Myelogenous, Chronic, BCR-ABL Positive - pathology
Male
Neoplasm, Residual
Pancytopenia - drug therapy
Pancytopenia - pathology
Piperazines - therapeutic use
Pyrimidines - therapeutic use
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0031-3025
1465-3931
DOI:10.1097/PAT.0b013e32834e42df